Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a sticker replace wires? wireless sensor for Kids' vital signs put to the test

NCT ID NCT07739823

Knowledge-focused Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This study evaluates a wireless, skin-adherent sensor called ANNE® Chest for continuous monitoring of heart rate, breathing rate, and temperature in hospitalized children from birth to 12 years old. The sensor's readings will be compared to standard bedside monitors to check its accuracy, safety, and comfort. If successful, it could offer a less intrusive way to track vital signs in pediatric intensive care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ANNE® Chest wireless skin-adherent sensor
What this could lead to
If validated, this wireless sensor could replace bulky wired monitors, making vital sign tracking in hospitalized children more comfortable and less restrictive.
What could go wrong
The sensor may not match the accuracy of standard monitors, or it could cause skin irritation. This is an early validation study, so success is not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 42 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Hospitalized neonates, infants, and children (0 days to \<12 years of age) admitted to the NICU or PICU at the Montreal Children's Hospital who require continuous physiologic monitoring and whose parent or legal guardian provides informed consent.

Ages

0 days to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Neonates (0-28 days of life) * Infants (29 days of life - 2 years, i.e., not turned 2 years old) * Children (2 years old - 12 years old, i.e., not turned 12 years old) Exclusion Criteria: * Contraindication to application of skin sensors (e.g., rash, surgical site, skin breakdown, open wounds, burns, active dermatitis, etc.) at the application site. * Severe hemodynamic instability requiring escalating interventions. * Congenital airway abnormalities interfere with accurate capnography. * Diagnosed neuromuscular disorders affecting respiratory mechanics. * Known adhesive allergies. * Inability to tolerate device placement due to behavioral issues. * Participation in conflicting clinical trials. * High-frequency oscillatory or mechanical ventilation. * Active bronchiolitis with mask intolerance. * Recent facial surgery preventing EtCO₂ nasal line placement. * Behavioral conditions preventing adherence to device wearing.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Physiologic monitoring are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Physiologic monitoring Vital signs monitoring

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.